Products for Research Use Only
RegisterLogin

Apolizumab

CAT: 0804-HY-P99442-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99442-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Apolizumab (Hu1D10) is a humanized monoclonal anti-Human leukocyte antigen-DR beta-chain antibody. Apolizumab can mediate apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro[1][2].
CAS Number
267227-08-7
Product Name Alternative
Hu1D10
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/apolizumab.html
Solubility
10 mM in DMSO
Smiles
[Apolizumab]
References & Citations
[1]Thomas S Lin, et al. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Leuk Lymphoma. 2009 Dec;50 (12) :1958-63.|[2]Matthew L. Hill DO, et al. In Vitro Activity of the Humanized Anti-HLA-DR Antibodies KRN848 and Apolizumab in Non-Hodgkins Lymphoma Cell Lines. Volume 106, Issue 11, 16 November 2005, Page 4826.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
CLA1060-01Apolizumab
GTR18337863Apolizumab Antibody
MBS1563354-01Research Grade Apolizumab
591671Apolizumab (HLA-DRB)
E55B0614Apolizumab (Reference antibody)
ICH5352-50mgApolizumab Biosimilar - Research Grade
GTR18698446-01Apolizumab Human Monoclonal Antibody
A135247Apolizumab Biosimilar (Monoclonal, IgG1-nd)
10-067Apolizumab (HLA-DRB) - Research Grade Biosimilar
GTR18117625Apolizumab (HLA-DRB) - Research Grade Biosimilar Antibody

Popular Products